External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home SABCS 2020
Roche and Genentech at

SABCS 2020

December 08 - December 12
San Antonio, USA
sabcs.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
09:00 AM
Duration 10mins Virtual
Patient-Reported Outcomes From the Phase 3 IMpassion031 Trial of Neoadjuvant Atezolizumabâ–¼ Plus Chemotherapy in Early Triple-Negative Breast Cancer
Mittendorf EA, Harbeck N, Zhang H, Saji S, Jung KH, Patel S, Patel S, Nguyen Duc A, Liste-Hermoso M, Chui SY, Barrios CH
Oncology | Breast Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:45 AM
Duration 10mins Virtual
Double-blind placebo (PBO)-controlled randomized phase III trial evaluating first-line ipatasertib (IPAT) combined with paclitaxel (PAC) for PIK3CA/AKT1/PTEN-altered locally advanced unresectable or metastatic triple-negative breast cancer (aTNBC): primary results from IPATunity130 cohort A
Dent R
Oncology | Breast Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.